DLAT, as a Cuproptosis-Related Gene, Regulates Kidney Renal Clear Cell Carcinoma Progression

被引:1
作者
Zhang, Peizhi [1 ]
Qiu, Jiechuan [2 ]
Wang, Qingliang [2 ]
Xu, Yingkun [3 ]
Wang, Zicheng [2 ]
Peng, Fan [1 ]
Hao, Yuhu [1 ]
Wu, Guangzhen [4 ]
Xia, Qinghua [1 ,2 ]
机构
[1] Shandong Univ, Shandong Prov Hosp, Cheeloo Coll Med, Dept Urol, Jinan 250021, Shandong, Peoples R China
[2] Shandong First Med Univ, Shandong Prov Hosp, Dept Urol, Jinan 250021, Shandong, Peoples R China
[3] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing 400042, Peoples R China
[4] Dalian Med Univ, Affiliated Hosp 1, Dept Urol, Dalian 116011, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
kidney renal clear cell carcinoma; dihydrolipidamide s-acetyltransferase; Cuproptosis; The Cancer Genome Atlas; Gene Expression Omnibus; PYRUVATE-DEHYDROGENASE COMPLEX; CANCER; AXIS;
D O I
10.23812/j.biol.regul.homeost.agents.20233703.128
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cuproptosis is a novel discovered cell death mechanism in cancers. This study aimed to investigate the expression and prognostic value of DLAT (dihydrolipidamide s-acetyltransferase), one of the Cuproptosis-related genes, in kidney renal clear cell carcinoma (KIRC) using a comprehensive analysis integrating bioinformatics and experimental assays.Methods: High-throughput data and clinical information of KIRC patients were downloaded from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. We used various R packages and bioinformatics analysis websites to analyze DLAT expression and function. Clinical tissue samples were used to verify DLAT expression in KIRC based on real-time quantitative reverse transcription (qRT-PCR) and immunohistochemistry. Subsequently, we validated DLAT differential expression in normal renal cells versus different KIRC cell lines using qRT-PCR. CCK-8 (cell counting kit-8) assay was used to assess the effect of DLAT overexpression on KIRC cells proliferation. Wound healing and Transwell assays were used to assess the effect of DLAT overexpression on KIRC cells invasion and migration.Results: DLAT mRNA expression in KIRC tumor tissue was lower than in normal kidney tissue. DLAT high expression suggested a good prognosis in KIRC. Gene ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed that DLAT was involved in a variety of biological functions and pathways. Infiltration analysis indicated that DLAT might affect the prognosis of KIRC by affecting immune infiltration in the KIRC tumor microenvironment. qRT-PCR and immunohistochemistry further DLAT low expression in KIRC compared to normal kidney tissue. Besides, we found that DLAT overexpression could not only inhibit KIRC cells growth, but also effectively inhibit the migration and invasion of KIRC cell lines.Conclusions: This study explored the expression of DLAT in KIRC and the effect of DLAT on the proliferation, migration, and invasion of renal cancer cell lines, which has a positive role in guiding the diagnosis and treatment of KIRC.
引用
收藏
页码:1267 / 1283
页数:17
相关论文
共 50 条
[21]   Identification and Validation of Cuproptosis-Related Signature to Predict Prognosis and Characterize Tumor Immune Infiltration in Kidney Clear Cell Carcinoma [J].
Ding, Yan ;
Zhao, Lei ;
Zhang, Lijun ;
Zhang, Xuanzhi ;
Gu, Ting ;
Zhang, Yanjin ;
Bu, Liwen ;
Zhang, Shuyi ;
Luo, Jue .
INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2025,
[22]   Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma [J].
Wang, Tao ;
Liu, Yufeng ;
Li, Qing ;
Luo, Yang ;
Liu, Dawei ;
Li, Bin .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[23]   Comprehensive analysis identifies cuproptosis-related gene DLAT as a potential prognostic and immunological biomarker in pancreatic adenocarcinoma [J].
Zhang, Xiaoling ;
Zhou, Yuxin ;
Hu, Jiahe ;
Yu, Xuefeng ;
Xu, Haitao ;
Ba, Zhichang ;
Zhang, Haoxin ;
Sun, Yanan ;
Wang, Rongfang ;
Du, Xinlian ;
Mou, Ruishu ;
Li, Xuedong ;
Zhu, Jiuxin ;
Xie, Rui .
BMC CANCER, 2023, 23 (01)
[24]   Systematic pan-cancer analysis identifies cuproptosis-related gene DLAT as an immunological and prognostic biomarker [J].
Xu, Lidong ;
Wu, Peipei ;
Rong, Aimei ;
Li, Kunkun ;
Xiao, Xingguo ;
Zhang, Yong ;
Wu, Huili .
AGING-US, 2023, 15 (10) :4269-4287
[25]   Prognosis, Immune Microenvironment Infiltration and Immunotherapy Response in Clear Cell Renal Cell Carcinoma Based on Cuproptosis-related Immune Checkpoint Gene Signature [J].
Liu, Gang ;
Li, Feifei ;
Ge, Yuntian ;
Shi, Yaxing ;
Ren, Fang ;
Zhu, Liancheng .
JOURNAL OF CANCER, 2023, 14 (17) :3335-3350
[26]   Bioinformatics analysis and experimental validation of cuproptosis-related lncRNA LINC02154 in clear cell renal cell carcinoma [J].
Junlin Shen ;
Linhui Wang ;
Jianbin Bi .
BMC Cancer, 23
[27]   Bioinformatics analysis and experimental validation of cuproptosis-related lncRNA LINC02154 in clear cell renal cell carcinoma [J].
Shen, Junlin ;
Wang, Linhui ;
Bi, Jianbin .
BMC CANCER, 2023, 23 (01)
[28]   Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma [J].
Xie, Tongjin ;
Liu, Bin ;
Liu, Dongbo ;
Zhou, Yusong ;
Yang, Qingping ;
Wang, Dai ;
Tang, Mengjie ;
Liu, Wei .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[29]   Bioinformatics analysis and experimental validation of m6A and cuproptosis-related lncRNA NFE4 in clear cell renal cell carcinoma [J].
Feng, Rui ;
Li, Haolin ;
Meng, Tong ;
Fei, Mingtian ;
Yang, Cheng .
DISCOVER ONCOLOGY, 2024, 15 (01)
[30]   Sphingosine kinase 1 regulates lipid metabolism to promote progression of kidney renal clear cell carcinoma [J].
Zhao, Leizuo ;
Wang, Zicheng ;
Xu, Yingkun ;
Zhang, Peizhi ;
Qiu, Jiechuan ;
Nie, Dengke ;
Wu, Guangzhen ;
Chen, Chen ;
Chang, Yao ;
Xia, Qinghua .
PATHOLOGY RESEARCH AND PRACTICE, 2023, 248